✦ LIBER ✦

Screening for neuroblastoma: ethical and psychological aspects

✍ Scribed by Philip, T.; Ladenstein, R.; Kogner, P.; Perrier, L.; Bergeron, C.

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 59 KB
Volume: 31
Category: Article
ISSN: 0098-1532
DOI: 10.1002/(sici)1096-911x(199811)31:5<421::aid-mpo6>3.0.co;2-j

No coin nor oath required. For personal study only.

✦ Synopsis

General consideration is given to available data on screening and ethics. The particular ethical and psychological aspects of screening for neuroblastoma in very young children are highlighted.

Major aspects include differences between screening and curative medecine, responsabilities in screening, autonomy of children and parents, the principle of no harm, implementation procedures, and psychosocial effects.

Informed consent procedures are a major issue for neuroblastoma screening programs and have to be clarified during the consensus conference. Med.

📜 SIMILAR VOLUMES

Biological aspects of neuroblastoma scre

Biological aspects of neuroblastoma screening

✍ Brodeur, Garrett M.; Ambros, Peter F.; Favrot, Marie C. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 2 views

Abbreviations: CR ‫ס‬ complete response; VGPR ‫ס‬ very good partial response; HSR ‫ס‬ homogeneously

Screening for neuroblastoma in France: M

Screening for neuroblastoma in France: Methodological aspects and preliminary observations

✍ Chauvin, F.; Mathieu, P.; Frappaz, D.; Lasset, C.; Favrot, M.C.; Greffe, J.; Est 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

A pilot study of neuroblastoma mass screen-screening (one stage I, three stage II, one stage ing was initiated in January 1990 in the Rho ˆne III, three stage IVs). All are alive and well but French district. The expected number of births were good prognosis cases according to the per year is 26,000

Colloquy on Neuroblastoma Screening: Is

Colloquy on Neuroblastoma Screening: Is there a future for neuroblastoma mass screening?

✍ Bessho, Fumio 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

It is apparent that mass screening at the age of six months in Japan detects significant numbers of otherwise spontaneously regressing tumors. Nishi et al. estimated that at least 50% of tumors detected by screening with the HPLC method would otherwise regress spontaneously [31]. Considering that no

Mass screening for neuroblastoma in Japa

Mass screening for neuroblastoma in Japan

✍ Sawada, Tadashi; Nishi, Motoi; Takeda, Takeo; Iehara, Tomoko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Results of a 11-year-experience with mass screening for neuroblastoma in 6-month-old infants in Japan are presented. From 11,284,837 infants who were screened, 1,400 cases of neuroblastoma were detected, an incidence of 1/ 6,500-7,500 infants by HPLC screening. Most of the cases (75%) were at stages

Mass screening for neuroblastoma and mor

Mass screening for neuroblastoma and mortality in birth cohorts

✍ Motoi Nishi; Hirotsugu Miyake; Takeo Takeda; Junji Hanai; Yuko Kikuchi; Nobuo Ta 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 33 KB 👁 2 views

Mortality resulting from neuroblastoma in birth cohorts in both Sapporo City and the whole of Japan was investigated to evaluate the effects of a high-performance liquid chromatography (HPLC) mass screening program, targeting on 6 monthold infants. In Sapporo City, the non-HPLC screened cohort showe

Neuroblastoma. Mass screening for early

Neuroblastoma. Mass screening for early detection and its prognosis

✍ Tadashi Sawada; Takuro Kidowaki; Izumi Sakamoto; Tetsuo Hashida; Takafumi Matsum 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB 👁 1 views